← All companies

ARCT

Arcturus Therapeutics Holdings Inc.

ARCT Nasdaq Pharmaceutical Preparations EDGAR ↗

$6.00

+0.08 +1.35%

Key statistics

from XBRL data in SEC filings

Market cap

$171M

Revenue (TTM)

$54.7M

Net income (TTM)

-$78.7M

EPS (TTM)

$-2.83

P/E ratio

—

Dividend yield

—

Free cash flow

-$74.5M

Cash

$211M

Total assets

$245M

Gross margin

—

52-week range

$5.50 – $24.17

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Regulation FD disclosure Jul 2, 2026 8-K Shareholder vote results Jun 5, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure May 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 3, 2026 8-K Results of operations (earnings release) Mar 3, 2026 8-K Director or officer change Dec 15, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Regulation FD disclosure; Other events Oct 22, 2025 8-K Regulation FD disclosure Sep 26, 2025 8-K Regulation FD disclosure Aug 29, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release) Aug 11, 2025 8-K Regulation FD disclosure Jun 30, 2025 8-K Shareholder vote results Jun 6, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 10-K Fiscal year ended 2024-12-31 Mar 6, 2025 8-K Results of operations (earnings release) Mar 6, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Regulation FD disclosure Aug 13, 2024 10-Q Quarter ended 2024-06-30 Aug 5, 2024 8-K Results of operations (earnings release) Aug 5, 2024 8-K Director or officer change; Regulation FD disclosure Jun 24, 2024 8-K Director or officer change; Shareholder vote results Jun 14, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 8-K Changed accountants Apr 5, 2024 8-K Regulation FD disclosure Mar 19, 2024 10-K Fiscal year ended 2023-12-31 Mar 14, 2024 8-K/A Results of operations (earnings release) Mar 14, 2024 8-K Results of operations (earnings release) Mar 7, 2024 8-K Director or officer change Feb 23, 2024 10-Q Quarter ended 2023-09-30 Nov 14, 2023 8-K Results of operations (earnings release) Nov 14, 2023 8-K Entered a material agreement; Other events Sep 26, 2023 8-K Entered a material agreement; Other events Aug 14, 2023 10-Q Quarter ended 2023-06-30 Aug 7, 2023